Between March 12 and March 19, 2026, the FDA announced three separate voluntary nationwide recalls of consumer products found to contain undeclared prescription erectile dysfunction drugs — sildenafil, tadalafil, or both — posing potentially life-threatening risks to consumers with heart conditions.
Why It Matters
These recalls highlight a persistent shadow market in sexual enhancement products that circumvents FDA oversight by hiding prescription pharmaceuticals in "natural" supplements, chocolates, and honey. For the legitimate sexual wellness industry, tainted products erode consumer trust and invite broader regulatory scrutiny. The pattern also underscores why mainstream retailers like Amazon are tightening supplement verification requirements — and why consumers should be skeptical of "natural" sexual enhancement claims from unestablished brands.On March 19, Gear Isle recalled Gold Lion Aphrodisiac Chocolate Sachet and Ilum Sex Chocolate after FDA testing found both contained undeclared sildenafil and tadalafil. On March 14, Tampa-based Pure Vitamins and Natural Supplements LLC recalled Boner Bear Honey (undeclared sildenafil and tadalafil), as well as Red Bull Extreme and Blue Bull Extreme products (undeclared sildenafil). On March 12, Primal Supplements Group LLC recalled Primal Herbs Volume after FDA analysis found undeclared sildenafil in units shipped between July 2 and September 19, 2025.
The core danger is drug interaction: sildenafil and tadalafil can cause sudden, severe drops in blood pressure when combined with nitrates commonly prescribed for chest pain and other cardiac conditions — a combination that can be fatal. No adverse events have been reported for any of the three recalls, but the FDA emphasized that absence of reported harm does not eliminate the risk, particularly for the primary target demographic of adult men who are more likely to have undiagnosed cardiovascular conditions.
Sources
- FDA issues chocolate recall warning that poses danger to men — Newsweek
- Pure Vitamins and Natural Supplements LLC Issues Voluntary Nationwide Recall — FDA
- Primal Herbs Issues Voluntary Nationwide Recall — FDA
Update — 2026-03-28
Initial entry — story first created.
Update — 2026-04-20
The pattern continued into April. On April 7, 2026, the FDA posted a new voluntary nationwide recall of Nalpac's "DTF Sexual Chocolate" after testing found undeclared sildenafil and tadalafil. The recall expanded between April 8 and April 10 to include additional SKUs and a follow-on recall from Gear Isle covering its "Gold Lion" and "ilum Sex Chocolate" products. Nalpac is a major adult-industry distributor — meaning the tainted chocolate moved through established adult-retail channels rather than only obscure e-commerce fronts, broadening the exposure surface for end consumers.
The April wave brings the total to at least six FDA-listed consumer-product recalls in March and April 2026 involving hidden sildenafil or tadalafil. The regulatory message is escalating: FDA is now pairing recall announcements with public messaging that explicitly names the adult-retail distribution channel, and Amazon's March 31 cGMP-verification enforcement deadline for sexual-enhancement supplements leaves major marketplace volume with tighter testing requirements than the physical-retail channel being hit now.
New Sources
- FDA — Nalpac Issues Voluntary Nationwide Recall of DTF Sexual Chocolate
- Food Safety News — Chocolate recalled because it contains erectile dysfunction drug
- Consumer Affairs — Sexual enhancement chocolate recalled
Update — 2026-10-01
Honey traps, again. On September 25, 2026, the FDA posted two new Medication Health Fraud notices for "sexual enhancement" honey products sold online.
- Miracle Power of King Kong Honey. FDA lab analysis confirmed undeclared tadalafil, the active ingredient in Cialis. The product was sold through usroyalhoney.com and "possibly in some retail stores."
- Vital Honey. This is an expansion of a 2022 warning. FDA testing confirmed that additional versions of the product, now also sold through usroyalhoney.com, contain tadalafil. The 2022 notice involved different storefronts (wholesaleonline1.com and thirstyrun.com), so the brand has outlasted at least one round of enforcement and moved to a new domain.
The FDA repeats its standard warning: undeclared PDE5 inhibitors can interact with nitrates such as nitroglycerin and drop blood pressure to dangerous levels, a particular risk for men with diabetes, hypertension, high cholesterol or heart disease. Those are the men most likely to have ED and to seek a "natural" fix. The FDA also says it cannot test every product and that these notices are not exhaustive.
What changed since our last update: The spring cluster in this story was mostly chocolate and capsule products moving through adult-retail distribution. This batch is honey sachets, the same format Australia's TGA flagged in August. They are tied to a named web storefront, and one product is a repeat offender. That points to a domain-hopping problem rather than a one-off. Together with September's A&P Creations recall of X10 and biQ-FEL through Amazon and Walmart.com, it makes at least three spiked male-enhancement products FDA has acted on in about two weeks.
New Sources
- Miracle Power of King Kong Honey may be harmful due to hidden ingredient — U.S. FDA
- Public Notification: Vital Honey contains hidden drug ingredient — U.S. FDA
Update — 2026-10-08
The problem goes transatlantic: Spain and the Czech Republic pull spiked "natural" boosters. Regulators in two EU member states acted the same week against supplements hiding the ED drug sildenafil.
- Czech Republic, October 6, 2026. The Czech Agriculture and Food Inspection Authority (CAFIA) detected sildenafil in two food-supplement batches. ELIXIRMAN (8 × 300 mg capsules) was sold by ELIXIRMAN s.r.o. of Prague, with a manufacturer listed in China, and was bought by inspectors on elixirman.cz. Capatrex (10 capsules) was found in a retail shop in Karlovy Vary, with a listed manufacturer in Milton Keynes, UK. The National Institute of Public Health said the sildenafil was present at a level corresponding to a therapeutic dose and judged both products injurious to health under EU Regulation 178/2002, posing "a high health risk to sensitive or not fully healthy consumers." CAFIA ordered the sellers to stop sales. The Capatrex distributor said it had supplied five wholesalers.
- Spain, October 7, 2026. The Spanish Agency of Medicines and Medical Devices (AEMPS) suspended sales and ordered withdrawal of all batches of "El Toro," after its official control laboratory confirmed undeclared sildenafil. The product was marketed "as natural," hiding its real composition. AEMPS learned of it from the Asturias police. The agency warned that PDE-5 inhibitors are contraindicated in people with heart failure, unstable angina, recent heart attack, uncontrolled blood pressure and certain retinal disorders, and interact with many medications.
What changed: Until now this story has been about the FDA, with one Australian TGA note in August. European food and medicines regulators are now finding the same adulterated "sexual enhancement" supplements. The Czech case is notable because a UK-listed manufacturer turned up in an EU retail shop, a cross-border supply chain the FDA's US-only notices can't reach. For legitimate libido and wellness supplement brands, each enforcement round increases the regulatory suspicion around the whole category.